Zynerba Pharmaceuticals Rises Due to Patent NewsZynerba PharmaceuticalsZynerba Pharmaceuticals (ZYNE) has risen 18.6% as of 10:40 AM EST on June 11. The stock has been among the top-performing stocks this year. The stock has year-to-date gains of